3 Stocks Under $50 We’re Skeptical Of
3 Stocks Under $50 We’re Skeptical Of
3 of Wall Street’s Favorite Stocks We Keep Off Our Radar
3 of Wall Street’s Favorite Stocks We Keep Off Our Radar
3 Small-Cap Stocks That Fall Short
3 Small-Cap Stocks That Fall Short
3 Unprofitable Stocks That Fall Short
3 Unprofitable Stocks That Fall Short
Medifast Scientific & Clinical Affairs Team Showcases New Research in Metabolic Health at ObesityWeek Conference
Company’s Clinical Heritage and Leadership in Metabolic Health Highlighted Through Poster Presentations and Expert Contributions
5 Insightful Analyst Questions From Medifast’s Q3 Earnings Call
5 Insightful Analyst Questions From Medifast’s Q3 Earnings Call
MED Q3 Deep Dive: Focus Shifts to Metabolic Health Amid Industry Challenges
MED Q3 Deep Dive: Focus Shifts to Metabolic Health Amid Industry Challenges
Medifast (NYSE:MED) Posts Q3 Sales In Line With Estimates
Medifast (NYSE:MED) Posts Q3 Sales In Line With Estimates
Medifast Announces Third Quarter 2025 Financial Results
Medifast (NYSE: MED), the health and wellness company known for its science-backed, coach-guided lifestyle system, today reported results for the third quarter ended September 30, 2025. ...